MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
Annals of hematology
View this publicationMember
Medical Faculty, University of Bonn University Hospital of Bonn Sigmund-Freud-Strasse 25 53105 Bonn
Annals of hematology
View this publicationHemaSphere
View this publicationEMBO molecular medicine
View this publication